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Myeloid-derived suppressor cells (MDSCs) are well
known regulators of regulatory T cells (Treg cells);
however, the direct regulation of MDSCs by Treg
cells has not been well characterized. We find
that colitis caused by functional deficiency of Treg
cells leads to altered expansion and reduced func-
tion of MDSCs. During differentiation of MDSCs
in vitro from bone marrow cells, Treg cells enhanced
MDSC function and controlled their differentiation
through a mechanism involving transforming growth
factor-b (TGF-b). TGF-b-deficient Treg cells were not
able to regulate MDSC function in an experimentally
induced model of colitis. Finally, we evaluated the
therapeutic effect of TGF-b-mediated in-vitro-differ-
entiated MDSCs on colitis. Adoptive transfer of
MDSCs that differentiated with TGF-b led to better
colitis prevention than the transfer of MDSCs that
differentiated without TGF-b. Our results demon-
strate an interaction between Treg cells and MDSCs
that contributes to the regulation of MDSC prolif-
eration and the acquisition of immunosuppressive
functions.
INTRODUCTION
Myeloid-derived suppressor cells (MDSCs) are a heterogeneous
population of cells composed of immature myeloid cells,
including precursors of macrophages, granulocytes, dendritic
cells, and myeloid cells at early stages of differentiation (Serafini
et al., 2006). In mice, MDSCs are defined as CD11b+Gr1+ cells
and are normally present in low numbers in the bone marrow
and spleen of healthy mice (Marigo et al., 2008). However, in
response to inflammatory diseases, MDSCs accumulate in
greater numbers in the spleen, blood, and lymph nodes (Gabri-
lovich and Nagaraj, 2009), where they suppress immune
responses (Delano et al., 2007; Haile et al., 2010; MarhabaCell Repor
This is an open access article under the CC BY-Net al., 2007). MDSCs in mice can be further characterized
by two epitopes recognized by the anti-Gr1 antibodies
Ly6G and Ly6C. These epitopes allow for the classification
of MDSCs into two distinct subsets with distinct tissue distribu-
tion and function: granulocytic MDSCs (Gr-MDSCs, CD11b+
Ly6GhighLy6Clow) and monocytic MDSCs (Mo-MDSCs, CD11b+
Ly6GdimLy6Chi) (Bronte, 2009; Haile et al., 2010). The granulo-
cytic and monocytic subsets of MDSCs use different mecha-
nisms to suppress T cell proliferation. Gr-MDSCs express high
levels of arginase 1 (ARG1) and produce reactive oxygen spe-
cies (ROSs), whereas low levels of ARG1 and high levels of nitric
oxide (NO) production by inducible nitric oxide synthase (iNOS)
characterize the monocytic subset (Gabrilovich and Nagaraj,
2009; Youn et al., 2008).
Human inflammatory bowel disease (IBD) encompasses
several diseases, including Crohn’s disease and ulcerative coli-
tis (Baumgart and Sandborn, 2007). Studies with murine models
of IBD, which mimic many of the features found in human IBD,
have shown that the disease results from an imbalance of
effector and regulatory T cells (Treg cells) (Maloy and Kullberg,
2008). MDSC levels are elevated in T cell-dependent colitis,
and this serves to protect mice from developing intestinal
inflammation (Haile et al., 2008). Treg cells play an important
role in maintaining self-tolerance and preventing autoimmunity
by suppressing self-reactive cells (Sakaguchi et al., 2006).
Moreover, Treg cells have been shown to play an important
role in intestinal homeostasis (Saurer and Mueller, 2009). Treg
cells express cell surface markers, particularly CD4 and CD25,
along with the lineage-specific transcription factor Foxp3 (Fon-
tenot et al., 2003; Hori et al., 2003). In addition, Mo-MDSCs can
suppress tumor-specific T cell responses directly by secreting
NO, transforming growth factor-b (TGF-b), and interleukin-10
(IL-10) and indirectly by converting peripherally derived Treg
cells (Huang et al., 2006). However, the effect of Treg cells on
MDSCs has not been determined.
We report that Treg cell-derived TGF-b is a crucial controller of
MDSC proliferation and function in murine colitis. We have also
identified a role for Treg cells in regulating MDSCs and also
show a functional interaction between Treg cells and MDSCs
in colitis.ts 17, 3219–3232, December 20, 2016 ª 2016 The Author(s). 3219
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
RESULTS
MDSCs from Pdk1flox/flox;CD4-Cre Mice Have Impaired
Immune-Suppressive Functions Compared with MDSCs
from Pdk1flox/+;CD4-Cre Mice
Deletion of the phosphoinositide-dependent protein kinase 1
(Pdk1) gene by CD4-Cre (T cell-specific deletion) impairs the
function of Treg cells, thereby leading to spontaneous colitis in
Pdk1flox/flox;CD4-Cre mice because functionally defective Treg
cells cannot regulate the activation of TCRgd+ T cells, whose
Pdk1 gene remains intact (Park et al., 2010). The mice that
develop colitis (Pdk1flox/flox;CD4-Cre) show a high incidence
of rectal prolapse, unlike wild-type littermate control mice
(Pdk1flox/+;CD4-Cre), which were bred in the same cages. Inter-
estingly, the CD11b+Gr1+ MDSC population and the severity of
intestinal inflammation increased with age. CD11b+Gr1+ cells
were isolated using a Ficoll density gradient, effectively removing
granulocytes, including inflammatory neutrophils (Condamine
et al., 2014), and the remaining cells were assumed to be
MDSCs. In young mice (6–8 weeks old), Pdk1flox/flox;CD4-Cre
mice showed a similar percentage of MDSCs in the spleen and
lymph nodes compared with Pdk1flox/+;CD4-Cre mice (Figures
1A and 1B). However, in older mice (more than 12 weeks old),
the population of MDSCs in the spleen and lymph nodes
was much higher in Pdk1flox/flox;CD4-Cre mice compared with
Pdk1flox/+;CD4-Cre mice (Figures 1A and 1B). In these mice,
consistent with previous observations (Park et al., 2010),
PDK1-deficient Treg cells secreted far less TGF-b and IL-10 (Fig-
ure 1C). Interestingly, other immune-regulatory cells, such as
MDSCs, showed reduced functions in Pdk1flox/flox;CD4-Cre
mice compared with MDSCs from control (Pdk1flox/+;CD4-Cre)
mice. For example, expression of iNOS in Mo-MDSCs and
ARG1 in both Mo-MDSCs and Gr-MDSCs decreased in
Pdk1flox/flox;CD4-Cre mice compared with Pdk1flox/+;CD4-Cre
mice (Figure 1D). PD-L1 expression was also lower in both
Mo-MDSCs and Gr-MDSCs in Pdk1flox/flox;CD4-Cre mice
compared with Pdk1flox/+;CD4-Cremice (Figure 1E). In addition,
suppression of CD4+ T cell proliferation by Mo-MDSCs and Gr-
MDSCs from Pdk1flox/flox;CD4-Cre mice was weak compared
with MDSCs from Pdk1flox/+;CD4-Cremice (Figure 1F). Because
MDSCs regulate Treg cell expansion (Huang et al., 2006), the
ability of MDSCs to induce Treg cell differentiation in vitro was
also evaluated under suboptimal conditions with a reduced
amount of TGF-b. Our results suggest that induction of induced
Treg cell (iTreg cell) differentiation in vitro by MDSCs from
Pdk1flox/flox;CD4-Cre mice was less efficient than induction of
iTreg cell differentiation in vitro by MDSCs from Pdk1flox/+;
CD4-Cre mice (Figure 1G; Figure S1). In addition, increasing
iTreg differentiation by MDSCs from Pdk1flox/+;CD4-Cre mice
was considerably affected by anti-PD-L1 antibody, whereas
this was modestly affected by anti-IL-10 antibody (Figure 1G;
Figure S1).
Adoptive Transfer of Wild-Type Treg Cells Restored the
Immune-Modulatory Functions of MDSCs in Pdk1flox/flox;
CD4-Cre Mice
We next evaluated whether MDSC function could also be
affected by Treg cells because the function of MDSCs was3220 Cell Reports 17, 3219–3232, December 20, 2016significantly reduced in mice deficient in Treg cell function (Fig-
ure 1F). For this purpose, we used a mouse model for colitis
where inflammation of the intestines is induced by dextran
sodium sulfate (DSS) (Figure S2A). Our result showed that
reduced body weight in mice with DSS-induced colitis was
not significantly reversed by adoptive transfer of MDSCs from
Pdk1flox/flox;CD4-Cre mice (Figure 2A). However, when MDSCs
from wild-type Treg cell-injected Pdk1flox/flox;CD4-Cre mice
were transferred into mice with DSS-induced colitis, body
weight improved dramatically (Figure 2A). Colon length is a
proven and useful indicator of the severity of colitis (Araki
et al., 2005). After 11 days of DSS treatment, mice were sacri-
ficed, and colon length was measured. Our results show that
DSS-treated mice had significantly shorter colons compared
with unexposed mice, whereas adoptive transfer of MDSCs
from Pdk1flox/flox;CD4-Cre mice did not affect colon length in
DSS-treated mice (Figure 2B; Figure S2B). However, transfer
of MDSCs from wild-type Treg cell-injected Pdk1flox/flox;
CD4-Cre mice restored colon length to normal in DSS-treated
mice, and this was consistent with weight gain (Figures 2A
and 2B). Histological examination of colon sections prepared
from normal and DSS-treated mice also showed that recovery
from intestinal inflammation and injury could be improved
by transfer of MDSCs from wild-type Treg cell-injected
Pdk1flox/flox;CD4-Cre mice (Figures 2C and 2D). However,
transfer of MDSCs from Pdk1flox/flox;CD4-Cre mice had no
appreciable effect on reducing intestinal inflammation and/or
tissue injury (Figures 2C and 2D). Finally, it is important
to note that the transfer of MDSCs from wild-type Treg cell-
injected Pdk1flox/flox;CD4-Cre mice, but not MDSCs from
Pdk1flox/flox;CD4-Cremice, caused a decline in production of cy-
tokines such as IL-10, IL-17A, and interferon g (IFN-g) from
cultured intestinal tissue (Figure 2E).
Treg Cells Regulate MDSC Differentiation
In Pdk1flox/flox;CD4-Cre mice, Treg cell function was dramati-
cally impaired, leading to spontaneous colitis in the mice; how-
ever, colitis was not induced when the mice received adoptively
transferred wild-type Treg cells (Figure 3A). In Pdk1flox/flox;
CD4-Cre mice with colitis, the subpopulation of Gr-MDSCs
(CD11b+Ly6GhighLy6Clow) was enriched compared with Mo-
MDSCs (CD11b+Ly6GdimLy6Chi) (Figure 3B). However, these
changes in MDSC subpopulations reverted to normal levels
upon adoptive transfer of wild-type Treg cells (Figure 3B). The
proportion of Mo-MDSCs among the total MDSCs increased
following the transfer of wild-type Treg cells, but the proportion
of Gr-MDSCs was lower after the transfer of wild-type Treg
cells into Pdk1flox/flox;CD4-Cre mice (Figure 3B). Therefore,
Treg cells modulate the differentiation of a distinct subpopula-
tion of MDSCs.
MDSCs can differentiate from bone marrow cells in vitro by
co-culture with granulocyte-macrophage colony-stimulating
factor (GM-CSF), IL-4, and 2-mercaptoethanol (2-ME), along
with unidentified tumor-derived factors, after 3–5 days in
culture (Youn et al., 2008). However, our data show that
MDSCs can be generated without tumor-derived factors, and
at least two distinct MDSC subpopulations, Mo-MDSCs and
Gr-MDSCs, were derived from bone marrow cells (Figure 3).
Figure 1. Immune-Suppressive Functions of MDSCs from Pdk1flox/flox;Cd4-Cre Mice Were Reduced Compared with MDSCs from
Pdk1flox/+;Cd4-Cre Mice
(A) Flow cytometric analysis of MDSCs in the spleen and lymph nodes of Pdk1flox/+;CD4-Cre (flox/+) and Pdk1flox/flox;CD4-Cre (flox/flox) mice. Data are presented
as a representative fluorescence-activated cell sorting (FACS) plot.
(B) The percentage of MDSCs in the lymph nodes (top) or in the spleen (bottom) by age (n = 4–5 mice/group).
(C) Relative levels of TGF-b (left) and IL-10 (right) mRNAs in Treg cells after activation with anti-CD3 and anti-CD28 antibodies. Data are representative of four
independent experiments.
(D) Relative levels of iNOS mRNA (left) in splenic Mo-MDSCs and relative levels of ARG1 mRNA (right) in splenic Mo-MDSCs and Gr-MDSCs. Data are repre-
sentative of three independent experiments.
(E) Flow cytometric analysis of PD-L1 expression in splenic Mo-MDSCs and Gr-MDSCs. Data are representative of two independent experiments.
(F) Suppression assay with isolated MDSCs.
(G) Flow cytometric analysis of in vitro- induced Treg cells (iTreg) withMo-MDSCs andGr-MDSCs isolated from the spleen. For blocking of IL-10 and PD-L1, anti-
IL-10 (10 mg/mL) and anti-PD-L1 (10 mg/mL) antibodies were added to iTreg cells during differentiation.
Data are representative of three (F and G) independent experiments. Results are expressed as themean ±SD. *p < 0.05, **p < 0.01 by Student’s t test (C and D) or
one-way ANOVA and Tukey post-test (F and G). See also Figure S1.In support of these findings, a recent study showed that
MDSCs can be generated from bone marrow cells without tu-
mor-derived factors (Messmann et al., 2015). To confirm the
ability of Treg cells to modulate differentiation of distinct
MDSC subpopulations, bone marrow cells were allowed todifferentiate into MDSCs, with or without Treg cells, in the
absence or presence of GM-CSF, IL-4, and 2-ME. In the
absence of the cytokines, the Treg cells alone could not
induce differentiation of CD11b+Gr1+ MDSCs (Figure 3C). How-
ever, when bone marrow-derived MDSCs were allowed toCell Reports 17, 3219–3232, December 20, 2016 3221
Figure 2. Adoptive Transfer of Wild-Type Treg Cells Improves the Immune-Modulatory Functions of MDSCs
(A) Body weight change (in percentage) after adoptive transfer of MDSCs (5 3 105 cells) from Pdk1flox/flox;CD4-Cre (flox/flox) mice or from wild-type Treg cells
(2 3 105 cells) transferred Pdk1flox/flox;CD4-Cre (flox/flox + Treg cell) mice on day 6 of DSS treatment (n = 7–10 mice/group).
(B) Colon length was measured on day 11.
(C) Photomicrograph of a colon section. Scale bars, 100 mm.
(D) Histological grade of the colon sections.
(E) Measurement of cytokine levels in colon explants of DSS-treated mice on day 11 (n = 3 mice/group).
Data are representative of three (A–E) independent experiments. Results are expressed as the mean ± SD. *p < 0.05, **p < 0.01 by two-way ANOVA and
Bonferroni post-test (A) or one-way ANOVA and Tukey post-test (B, D, and E). See also Figure S2.differentiate in vitro in the presence of Treg cells with GM-CSF,
IL-4, and 2-ME, MDSC differentiation skewed toward Mo-
MDSCs (CD11b+Ly6GdimLy6Chi) (Figure 3D). This is consistent
with the observation that Treg cells also modulated the differ-
entiation of the Mo-MDSC subpopulation in Pdk1flox/flox;CD4-
Cre mice (Figure 3B).
As shown above, production of IL-10 and TGF-b was dramat-
ically lower in PDK1-deficient Treg cells compared with wild-
type Treg cells (Figure 1C). Thus, it was important to determine
whether Treg cell-produced cytokines such as TGF-b and
IL-10 could alter the differentiation of the two MDSC subpopula-
tions. Addition of TGF-b-neutralizing antibodies or a selective
inhibitor of the TGF-b receptor kinases, SB 431542, to bone
marrow cells prevented Treg cells from modulating the differen-
tiation of bone marrow-derived MDSCs into distinct subpopula-
tions (i.e., it reversed the increase in Mo-MDSCs and caused
a corresponding decrease in Gr-MDSCs) (Figure 3D). How-
ever, IL-10-neutralizing antibody did not affect differentiation
of MDSCs in vitro (data not shown).3222 Cell Reports 17, 3219–3232, December 20, 2016TGF-b Modulates the Differentiation of Bone Marrow-
Derived MDSCs
Addition of TGF-b directly to in vitro-differentiating MDSCs
caused the proportion of Gr-MDSCs to decrease, whereas the
proportion of Mo-MDSCs increased; however, IL-10 had no
effect on MDSC subpopulation differentiation (Figure 4A). Inter-
estingly, the absolute number of Gr-MDSCs did not decrease
substantially because the total number of differentiated MDSCs
increased (Figures 4B and 4C), meaning that the absolute num-
ber of Mo-MDSCs did, in fact, increase significantly in response
to TGF-b (Figure 4C). This is beneficial for producing large
numbers of MDSCs when these differentiated cells are used
for therapeutic purposes for patients suffering from inflammatory
diseases. Next, bone marrow-derived Mo-MDSCs and Gr-
MDSCs were isolated as they were undergoing differentiation
in vitro and labeled with carboxylfluorescein succinimidyl ester
(CFSE) to analyze dividing cells. Here, addition of TGF-b to the
MDSCs significantly increased the proliferation of Mo-MDSCs
but not Gr-MDSCs (Figure 4D). Interestingly, even though we
Figure 3. Adoptive Transfer of Wild-Type Treg Cells Affects MDSC Subpopulations
(A) Photomicrograph of colon sections (top) and their corresponding histological grades (bottom) of 12-week-old Pdk1flox/flox;CD4-Cre mice (flox/flox) before or
2 weeks after three separate adoptive transfers of wild-type Treg cells (23 105 cells) and a littermate control Pdk1flox/+;CD4-Cre (flox/+) (n = 3mice/group). Scale
bars, 100 mm.
(B) Flow cytometric analysis of MDSC subpopulations in Pdk1flox/+;CD4-Cre (flox/+) and Pdk flox/flox; CD4-Cre (flox/flox) mice before or 3 days after adoptive
transfer of wild-type Treg cells (2 3 105 cells).
(C) Flow cytometric analysis of bone marrow cells cultured in the absence of GM-CSF, IL-4, and 2-ME with or without Treg cells.
(D) Flow cytometric analysis of bonemarrow-derivedMDSCs differentiated in the presence of GM-CSF, IL-4, and 2-ME, with or without Treg cells. For blocking of
TGF-b signaling, anti-TGF-b antibody (10 mg/ml) or SB 431542 (10 mM) was used.
Data are representative of three (A and B) or four (C and D) independent experiments. Results are expressed as the mean ± SD. *p < 0.05, **p < 0.01 by one-way
ANOVA and Bonferroni post-test (A).isolated Mo-MDSCs as they were differentiating, some of these
cells spontaneously converted into Gr-MDSCs. However, none
of the Gr-MDSCswere converted intoMo-MDSCs, and the addi-
tion of TGF-b inhibited conversion ofMo-MDSCs intoGr-MDSCs
(Figure 4E). Also, others have shown that retinoblastoma (Rb) in-
hibits conversion of Mo-MDSC into Gr-MDSC (Youn et al., 2013).
Likewise, we found that TGF-b treatment increased Rb expres-sion in Mo-MDSCs (Figure 4F). In addition, we verified TGF-b
signaling in Mo-MDSCs and Gr-MDSCs to determine whether
these two populations show differences in TGF-b receptor
expression and phospho-Smad2/3 levels. Addition of TGF-b
increased TGF-bRII (b receptor type II) expression and phos-
pho-Smad2/3 levels in Mo-MDSCs but was unchanged in Gr-
MDSCs (Figure 4F; Figures S3A and S3B). To clarify the role ofCell Reports 17, 3219–3232, December 20, 2016 3223
(legend on next page)
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TGF-b signaling during MDSC differentiation, we used bone
marrow cells from Tgfbr2flox/flox mice and a recombinant retro-
virus (murine stem cell virus [MSCV]-Cre-internal ribosome entry
site [IRES]-GFP) to delete the Tgfbr2 gene in MDSCs. Here,
transduction of Mo-MDSCs was efficient because the great ma-
jority of GFP+ cells were Mo-MDSCs in the MDSC population
(Figure S3C). We then sorted GFP+ Mo-MDSCs and determined
the effect of Tgfbr2 gene deletion in mediating conversion of
Mo-MDSCs to Gr-MDSCs. We found that lack of Tgfbr2 expres-
sion in Mo-MDSCs abolishes Treg cell-mediated inhibition of
Mo-MDSC conversion into Gr-MDSCs, as did treatment of
Mo-MDSCs with TGF-b-neutralizing antibody (Figure 4G).
TGF-b Increases MDSC Inhibitory Functions
Before further investigating the bone marrow-derived MDSCs
that had differentiated in the presence of TGF-b in vitro
(MDSCsTGF-b), we confirmed that these cells were in an imma-
ture state by verifying the expression of the cell surface receptors
F4/80 (a macrophage marker) and CD11c (a dendritic cell
marker). However, very few of the bone marrow-derived MDSCs
had differentiated into mature myeloid cells, regardless of TGF-b
treatment (Figure 5A). In addition, differentiated MDSC and
MDSCTGF-b were sorted, and their nuclear morphology was
examined after staining with Wright-Giemsa stain. Gr-MDSCs
had a clearly visible polymorphonuclear morphology, whereas
Mo-MDSCs were mononuclear (Figure 5B).
The bone marrow-derived Mo-MDSCs produced molecules
involved in MDSC-mediated immune suppression, including
iNOS, IL-10, and TGF-b, but both Mo-MDSCs and Gr-MDSCs
expressed ARG1. Interestingly, TGF-b significantly enhanced
the production of iNOS, TGF-b, and IL-10 (Figure 5C) and
ARG1 (Figures 5D and 5E) in MDSCs. In addition, PD-L1 is
also important for MDSC-mediated immune modulation and
was found to be expressed on the surface of bone marrow-
derived MDSCs and particularly on Gr-MDSCs (Figure 5F).
Expression of PD-L1 on the surface of Mo-MDSCs was
enhanced by TGF-b, whereas the expression of PD-L1 by Gr-
MDSCs was not greatly affected by TGF-b (Figure 5F), possibly
because PD-L1 expression was already high on Gr-MDSCs
differentiated in vitro. Next, we determined the effect of TGF-b
on immune suppression by MDSCs. In our experiments, both
Mo-MDSCs and Gr-MDSCs, after being differentiated with
TGF-b, were more capable of suppressing CD4+ T cell prolifera-
tion than Mo-MDSCs and Gr-MDSCs differentiated without
TGF-b (Figure 5G).Figure 4. TGF-b Affects the Differentiation of Bone Marrow-Derived M
(A) Flow cytometric analysis of bone marrow-derived MDSCs differentiated with
(B) The number of bone marrow-derived MDSCs with or without the Treg cell-re
(C) Cell numbers of each subpopulation of bone marrow-derived MDSCs differe
(D) Flow cytometric analysis of proliferating CFSE-labeled bone marrow-derived
(E) Flow cytometric analysis of Mo-MDSCs andGr-MDSCs from purified bonema
Gr-MDSCs were purified from bonemarrow-derivedMDSCs that were differentiat
cultured for 3 days.
(F) Relative levels of Rb and TGF-bRII mRNA in bone marrow-derived Mo-MDSC
(G) Flow cytometric analysis of Mo-MDSCs and Gr-MDSCs from recombinant ret
Mo-MDSC after 3 days of culture with or without Treg cells. Anti-TGF-b antibody
Data are representative of five (A), three (B and C), or two (D–G) independent expe
way ANOVA and Tukey post-test (B) or two-way ANOVA and Bonferroni post-teTreg Cell-Derived TGF-b Is Crucial for Regulation of
MDSCs during DSS-Induced Colitis
As DSS-induced colitis progressed over time, we observed a
time-dependent (i.e., temporal) decrease in the population of
Treg cells, and this was accompanied by a concomitant increase
in the population of granulocytic MDSCs as the mice began to
lose weight (Figure S4). It is possible that, because the absolute
number of Treg cells was not significantly lower in the spleen, the
decrease in Treg cell population might result from an increase in
other inflammatory cells in the spleen (Figure S4A). However,
during recovery from colitis, the Treg cell population reverted
to a normal range, the population of granulocytic MDSCs
decreased, and themonocytic MDSC population increased (Fig-
ure S4B). Based on these results, we postulated that temporal
insufficiency of the Treg cell population affected the function of
MDSCs. To test this hypothesis, we transferred Treg cells into
mice with DSS-induced colitis at a time point just before the
Treg cell population started to decrease (Figure 6; Figure S5A).
When these mice received additional Treg cells under this proto-
col, weight gain improved dramatically (Figure 6A), and their co-
lons were not as dramatically short compared with DSS-treated
mice (Figure 6B; Figure S5B). In addition, recovery from intestinal
inflammation and injury in mice with DSS-induced experimental
colitis could be improved by adoptive transfer of Treg cells
(Figures 6C and 6D).
To confirm this crucial role of Treg cell-derived TGF-b in
regulating MDSCs, Treg cells transduced with TGF-b short
hairpin RNA (shRNA) were adoptively transferred into mice with
DSS-induced colitis (Figure 6A). Knockdown of TGF-b was
confirmed by ELISA prior to transferring Treg cells into mice (Fig-
ure 6E). Apparently, TGF-b-deficient Treg cells cannot signifi-
cantly reverse the symptoms associated with colitis, including
weight loss (Figure 6A), shortening of the colon (Figure 6B; Fig-
ure S5B), intestinal inflammation and injury (Figures 6C and
6D), and production of inflammatory cytokines by intestinal cells
(Figure 6F). Although wild-type Treg cells could regulate MDSC
subpopulations (Figures 6G and 6H) and functions (Figure 6I) in
mice with colitis, TGF-b-deficient Treg cells could regulate
neither the subpopulations (Figures 6G and 6H) nor their
functions (Figure 6I). Thus, our data show unequivocally that
Treg cell-derived TGF-b is a key mediator for modulating differ-
entiation of MDSCs into distinct subpopulations (Mo-MDSCs
and Gr-MDSCs) as well as for regulating MDSC function.
Moreover, adoptive transfer of TGF-b-deficient Treg cells into
Pdk1flox/flox;CD4-Cre mice did not contribute to differentiationDSCs
or without the Treg cell-related cytokines TGF-b and IL-10.
lated cytokines TGF-b and IL-10.
ntiated with or without TGF-b.
Mo-MDSCs or Gr-MDSCs differentiated with or without TGF-b.
rrow-derivedMo-MDSCs or Gr-MDSCs after 3 days of culture. Mo-MDSCs and
edwith or without TGF-b. The purifiedMo-MDSCs andGr-MDSCs were further
s and Gr-MDSCs differentiated with or without TGF-b.
rovirus (MSCV-Cre-IRES-GFP)-infected Tgfbr2+/+ Mo-MDSCs or Tgfbr2flox/flox
(10 mg/mL) was used to neutralize TGF-b.
riments. Results are expressed as the mean ± SD. *p < 0.05, **p < 0.01 by one-
st (C, E, and G) or Student t test (D and F). See also Figure S3.
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Figure 5. TGF-b Is Important for the Inhibitory Function of MDSCs
(A) Flow cytometric analysis of the expression of mature myeloid cell markers on bone marrow-derived MDSCs differentiated with or without TGF-b.
(B) Wright-Giemsa staining of bone marrow-derived MDSCs differentiated with or without TGF-b. Scale bars, 50 mm.
(C) Relative mRNA levels of iNOS (left), TGF-b (center), and IL-10 (right) in bone marrow-derived Mo-MDSCs differentiated with or without TGF-b after stimulation
with lipopolysaccharide (LPS).
(D) Relative mRNA levels of ARG1 in bone marrow-derived Mo-MDSCs and Gr-MDSCs differentiated with or without TGF-b.
(E) ARG1 activity in bone marrow-derived Mo-MDSCs and Gr-MDSCs differentiated with or without TGF-b.
(F) Flow cytometric analysis of PD-L1 expression on bone marrow-derived MDSC subpopulations differentiated with or without TGF-b after treatment with LPS,
GM-CSF + IL-4, or GM-CSF + IL-4 + LPS.
(G) Suppression assay with bone marrow-derived MDSCs.
Data are representative of two (A, F, and G) or three (B–E) independent experiments. Results are expressed as the mean ± SD. *p < 0.05, **p < 0.01 by two-away
ANOVA and Bonferroni post-test (C) or Student’s t test (D and E) or one-way ANOVA and Tukey post-test (G).of MDSC subpopulations, whereas wild-type Treg cells allowed
the differentiation (Figure S5C).
Mo-MDSCs Differentiated with TGF-b Showed
Enhanced Immune-Suppressive Activity in DSS-Induced
Experimental Colitis
To evaluate the therapeutic effect of TGF-b-mediated, in vitro-
differentiated MDSCs on inflammatory bowel disease, we
examined these cells in mice with DSS-induced colitis
(Figure S6A). Here, we focused on Mo-MDSCs because
these cells possess more potent inhibitory activity than Gr-
MDSCs (Gabrilovich and Nagaraj, 2009; Lindau et al., 2013;
Solito et al., 2014). In this experiment, mice were injected
intravenously with bone marrow-derived Mo-MDSC or Mo-3226 Cell Reports 17, 3219–3232, December 20, 2016MDSCTGF-b on day 1 and day 6 of DSS treatment. Our results
show that weight loss was less severe in DSS-treated mice
following the transfer of either Mo-MDSC or Mo-MDSCTGF-b,
and mice receiving Mo-MDSCTGF-b gained weight faster
compared with mice receiving Mo-MDSC (Figure 7A). Also,
the colon was shorter in mice with DSS-induced colitis, but,
after transfer of Mo-MDSCs, the colon was not as short,
whereas transfer of Mo-MDSCTGF-b led to nearly normal colon
length (Figure 7B; Figure S6B). Therefore, transfer of Mo-
MDSCTGF-b was more efficient at reversing intestinal inflamma-
tion and injury than the transfer of Mo-MDSCs, as evidenced
by histological analysis of colon sections (Figures 7C and
7D). In addition, transferred Mo-MDSCTGF-b was more local-
ized in the intestines compared with Mo-MDSCs (Figure 7E).
Figure 6. Treg Cell-Derived TGF-b Is Crucial for Regulation of MDSCs during DSS-Induced Colitis
(A) Body weight change (in percentage) after adoptive transfer of control shRNA-transduced or TGF-b shRNA-transduced Treg cells (2 3 105 cells) on day 5 of
DSS treatment (n = 6–7 mice/group).
(B) Colon length was measured on day 10 in the DSS-treated mice.
(C) Photomicrograph of colon sections. Scale bars, 100 mm.
(D) Histological grade of the colon sections.
(E) TGF-b shRNAwas introduced into Treg cells by using a recombinant lentiviruses, and the Treg cells were activatedwith anti-CD3 and anti-CD28 antibodies for
36 hr. Also, TGF-b production was measured by the TGF-b ELISA Ready-SET-Go system (eBioscience).
(F) Measurement of cytokine levels in colon explants from DSS-treated mice after adoptive transfer of control or TGF-b shRNA-transduced Treg cells on day 10
(n = 3 mice/group).
(G) Flow cytometric analysis of MDSC subpopulations from DSS-treated mice on day 7.
(H) The percentage of MDSC subpopulations in total MDSCs isolated from the spleen of DSS-treated mice on day 7.
(I) Relative levels of iNOS mRNA (left) in Mo-MDSCs and ARG1 mRNA (right) in Gr-MDSCs isolated from the spleens of DSS-treated mice.
Data are representative of two (A–I) independent experiments. Results are expressed as the mean ± SD. *p < 0.05, **p < 0.01 by two-way ANOVA and Bonferroni
post-test (A) or one-way ANOVA and Tukey post-test (B, D, H, and I), Holm-Sidak post-test (F), or Student’s t test (E). See also Figures S4 and S5.However, in other organs, including the lungs and secondary
lymphoid organs, there was not much difference in localization
of Mo-MDSC TGF-b and Mo-MDSCs (Figure S6C). Last, transfer
of Mo-MDSCTGF-b, but not Mo-MDSCs, led to large decreases
in cytokines such as IL-10, IL-17A, and IFN-g in cultured intes-
tinal tissues (Figure 7F).During intestinal inflammation, Treg cells are important for
regulating the inflammatory response. Thus, we evaluated Treg
cell populations in mice with DSS-induced colitis and found
that the proportion of CD4+Foxp3+ Treg cells was low. However,
when bone marrow-derived Mo-MDSC or Mo-MDSCTGF-b were
transferred into these mice, the population of CD4+Foxp3+Cell Reports 17, 3219–3232, December 20, 2016 3227
Figure 7. TGF-b-Educated MDSCs Show Enhanced Immune Suppression in DSS-Induced Colitis
(A) Body weight change (as percentage) after adoptive transfer of bone marrow-derived Mo-MDSCs or Mo-MDSCTGF-b (1 3 106 cells) on days 1 and 6 of DSS
treatment (n = 9–12 mice/group).
(B) Colon length was measured on day 11.
(C) Photomicrograph of colon sections. Scale bars, 100 mm.
(D) Histological grades of the colon sections.
(E) Mice were treated with DSS for 6 days and then injected with 1,10-dioctadecyl-3,3,30,30-tetramethylindocarbocyanine perchlorate (DiI)-labeled bone marrow-
derived Mo-MDSCs or Mo-MDSCTGF-b (4 3 106 cells). After 36 hr, fluorescence images of the intestine were obtained using the IVIS 200 imaging system.
(F) Measurement of cytokine levels in colon explants from DSS-treated mice on day 11 (n = 3 mice/group).
(G) Flow cytometric analysis of Treg cells in the spleen of DSS-treated mice on day 8.
(H) Flow cytometric analysis of proliferating CFSE-labeled Treg cells after stimulation with anti-CD3 and anti-CD28 antibodies in the presence of bone marrow-
derived Mo-MDSCs or Mo-MDSCTGF-b with or without anti-PD-L1 antibody (10 mg/mL) and anti-IL-10 antibody (10 mg/mL).
Data are representative of three (A–G) or two (H) independent experiments. Results are expressed as themean ±SD. *p < 0.05, **p < 0.01 by two-way ANOVA and
Bonferroni post-test (A) or one-way ANOVA and Tukey post-test (B, D, F, and G). See also Figure S6.
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Treg cell increased comparedwithDSS-treatedmice (Figure 7G).
Transfer of Mo-MDSCTGF-b resulted in a significant rise in total
splenic Treg cells compared with the transfer of Mo-MDSCs
(Figure 7G). Thus, Mo-MDSCTGF-bwasmore capable of inducing
Treg cell expansion than Mo-MDSCs. This observation was
also confirmed by assessing Treg cell proliferation in vitro.
Bone marrow-derived Mo-MDSCs and Mo-MDSCTGF-b both
enhanced the proliferation of Treg cells in vitro, but a greater ef-
fect was observed with Mo-MDSCTGF-b (Figure 7H). Moreover,
the enhanced proliferation of Treg cells by MDSCs was signifi-
cantly reduced when the function of IL-10 and PD-L1 was in-
hibited by adding antibodies to block IL-10 or PD-L1 (Figure 7H;
Figure S6D). This suggests that both PD-L1 and IL-10 are
responsible for promoting expansion of already differentiated
Treg cells, whereas PD-L1, but not IL-10, is important for iTreg
differentiation. In our adoptive transfer experiments, transferred
Mo-MDSC or Mo-MDSCTGF-b disappeared rapidly, whereas
intestinal inflammation was suppressed for longer periods.
Therefore, bone marrow-derived Mo-MDSCs, especially when
differentiated with TGF-b, cause Treg cells to expand in vivo
and in vitro, and this is the most likely explanation for the
prolonged immunosuppressive effects of Mo-MDSCs or Mo-
MDSCTGF-b, even though the transferred population disap-
peared relatively quickly.
DISCUSSION
MDSCs accumulate in the blood, lymphoid organs, spleen, and
tumors under inflammatory conditions (Gabrilovich and Nagaraj,
2009; Lindau et al., 2013; Solito et al., 2014) and are involved in
immune suppression by producing effector molecules such as
NO and ARG1 (Gabrilovich and Nagaraj, 2009; Solito et al.,
2014). In humans, MDSC populations are divided into two
groups (Gr-MDSCs and Mo-MDSCs), but these populations
have not been defined consistently with respect to surface
marker expression, leading to controversial results (Solito
et al., 2014). In mice, however, MDSCs are well defined as
CD11b+Gr1+ cells, and can be classified further as either Gr-
MDSCs or Mo-MDSCs (Gabrilovich and Nagaraj, 2009; Solito
et al., 2014). Although the classification of human MDSCs
by cell surface marker expression is controversial, human
MDSCs can be functionally characterized as Gr-MDSCs and
Mo-MDSCs. This is because, under inflammatory conditions,
Gr-MDSCs produce large quantities of ARG1 and ROS for im-
mune suppression, whereas Mo-MDSCs produce NO (Gabrilo-
vich and Nagaraj, 2009; Lindau et al., 2013; Solito et al., 2014).
In addition, others have shown that Gr-MDSCs are the major
subset of MDSCs to be expanded in the peripheral lymphoid
organs, whereas Mo-MDSCs possess more potent inhibitory
activity (Gabrilovich andNagaraj, 2009; Lindau et al., 2013; Solito
et al., 2014). In our study, the population of Gr-MDSCs was
expanded in Pdk1flox/flox; CD4-Cre mice as they developed
spontaneous colitis.
Many reports have shown that MDSCs induce the expansion
of Treg cells, which are involved indirectly in MDSC-mediated
immune suppression (Haile et al., 2008; Luan et al., 2013; Pan
et al., 2010; Serafini et al., 2008; Wood et al., 2012). In addition,
it has been reported that cell surface molecules expressed onMDSCs and effector molecules secreted by MDSCs are also
involved in MDSC-mediated expansion of Treg cells (Haile
et al., 2008; Luan et al., 2013; Pan et al., 2010; Serafini et al.,
2008; Wood et al., 2012). Thus, although MDSC-mediated Treg
cell expansion is well established, its effects on MDSC differen-
tiation and function have not been resolved. Here we show that
Treg cells control MDSC differentiation and function in a murine
model of colitis. The murine model of spontaneous colitis in
T cell-specific Pdk1-deficient mice favored conditions promot-
ing a deficiency of functional Treg cells, which allowed us to
examine the relationship between Treg cells and MDSCs. Under
these conditions, Treg cells had an important role in regulating
Mo-MDSC expansion and in regulating the function of both
Mo-MDSCs and Gr-MDSCs. In fact, in the spontaneous colitis
model, the number of Gr-MDSCs increased along with disease
severity. In contrast, for DSS-induced colitis, Gr-MDSCs also
increased initially but decreased in number as the mice recov-
ered from the experimentally induced colitis. Interestingly,
T cell-specific Pdk1-deficient mice with spontaneous colitis
began to recover after the transfer of wild-type Treg cells; the
number of Mo-MDSCs increased but Gr-MDSCs decreased in
the recipient mice, as seen in mice recovered from DSS-induced
colitis. Thus, our data suggest that Treg cells are important for
maintaining normal proportions of the MDSC subsets. In addi-
tion, because previous reports have shown that Mo-MDSCs
possessmore potent inhibitory activity thanGr-MDSCs (Gabrilo-
vich and Nagaraj, 2009; Lindau et al., 2013; Solito et al., 2014),
Treg cells may promote more immunosuppressive conditions
by favoring MDSC differentiation toward Mo-MDSCs.
In addition to the interaction of Treg cells with MDSCs in mice
with T cell-specific Pdk1 gene deficiency, we found that Treg
cell-derived TGF-b is important for regulating the differentiation
of MDSCs into distinct subpopulations and functions. Because
T cell-specific Pdk1 gene deficiency does not represent a phys-
iological condition, the importance of Treg cell-derived TGF-b for
regulation of MDSCs was confirmed in DSS-induced colitis, a
disease model used to mimic IBD (Bertrand et al., 2009; Klose
et al., 2014; Moriwaki et al., 2014). During acute intestinal inflam-
mation induced by DSS, the proportion of Treg cells decreased
rapidly. At this point, adoptive transfer of wild-type Treg cells, but
not of TGF-b-deficient Treg cells, helped to regulate MDSC sub-
populations and functions. This finding was supported directly
by experiments showing that the in vitro differentiation ofMDSCs
into Mo-MDSCs was affected by Treg cells, similar to what was
observed in vivo. Also, Treg cell-derived TGF-b was important
for the expansion of bone marrow-derived MDSCs into a Mo-
MDSC subpopulation in vitro. In addition to their effects on
MDSC differentiation, TGF-b was also crucial for MDSC func-
tions. Aside from inflammatory conditions such as colitis, this
interaction may also protect tumors from anti-tumor immunity;
many reports have detailed a negative correlation between
Treg cells and MDSCs and the prognosis of cancer patients
(Arihara et al., 2013; Gabitass et al., 2011; Tazzari et al., 2014;
Wu et al., 2014). Therefore, it is possible that Treg cells and
MDSCs can establish a positive feedback loop during the inflam-
matory response and tumor environment.
In conclusion, Treg cells are capable of regulating MDSCs un-
der pro-inflammatory conditions. There is a positive feedbackCell Reports 17, 3219–3232, December 20, 2016 3229
loop between MDSCs and Treg cells during the inflammatory
response, where MDSCs support the expansion of Treg cells,
and Treg cells modulate MDSC differentiation and effector func-
tions via TGF-b. Theseobservations reveal an interactionbetween
MDSCsandTregcells andprovide insight into immune regulation.
In addition, our in vitro MDSC differentiation strategy can be
applied to cell-based therapeutic strategies for patients suffering
from inflammatory diseases, including IBD, because TGF-b
enhanced MDSC function and also increased MDSC numbers.
EXPERIMENTAL PROCEDURES
Mice and MDSC Isolation
Pdk1flox/flox mice were bred with CD4-Cre transgenic mice, and the offspring
were bred with Pdk1flox/flox mice to generate Pdk1flox/flox;CD4-Cre and
Pdk1flox/+;CD4-Cre. All mice were kept under specific pathogen-free condi-
tions in the animal care facility at the Gwangju Institute of Science and Tech-
nology (GIST). All experiments using mice were approved by the Institutional
Animal Care and Use Committee of GIST. MDSCs were stained with MDSC-
specific surface markers and isolated with a FACSAria III instrument (BD
Biosciences) after cell isolation using a Ficoll density gradient (GE Healthcare)
to remove granulocytes.
Flow Cytometry
Isolated or differentiated cells were stained with the indicated antibodies and
analyzed on a FACSCanto II (BD Biosciences) or Guava flow cytometer (Milli-
pore). Live cells were gated by forward and side scatters for analysis. For intra-
cellular staining to detect Foxp3, cells were fixed and permeabilized with
Foxp3 staining buffer (eBioscience). The data were analyzed using FlowJo
software.
Treg Cell Isolation and In Vitro Treg Cell Differentiation
CD4+CD25+ lymph node cells from Pdk1flox/flox; CD4-Cre or Pdk1flox/+; CD4-
Cre mice were sorted on a FACSAria III instrument (BD Biosciences)
after staining cells with fluorochrome-conjugated anti-mouse CD4 (GK 1.5,
eBioscience) and anti-mouse CD25 (PC61.5, eBioscience) antibodies. Details
of in vitro Treg cell differentiation can be found in the Supplemental Experi-
mental Procedures.
Adoptive Transfer of Treg Cells
Wild-type Treg cells (CD4+CD25+) were isolated from lymph nodes of C57BL/6
mice with a FACSAria III instrument (BD Biosciences). Before transfer, we
confirmed that more than 95% of the isolated CD4+CD25+ cells were
Foxp3+ cells. Pdk1flox/flox; CD4-Cre and Pdk1flox/+; CD4-Cre mice were
injected intravenously twice with the isolated wild-type Treg cells.
qRT-PCR
Total RNA was isolated from cell pellets using the RNeasy mini kit (QIAGEN),
and first-strand cDNA was subsequently synthesized using RT Drymix (Enzi-
nomics) according to the manufacturer’s instructions. The amount of each
mRNA was determined by real-time PCR (Agilent Technologies) using SYBR
Premix (Takara). All experiments were normalized using the glyceraldehyde-
3-phospate dehydrogenase gene.
In Vitro Differentiation of Bone Marrow-Derived MDSCs
Bone marrow cells were isolated from C57BL/6 mice, and 5 3 105 cells
were cultured in 0.5 mL of RPMI 1640 medium (HyClone) supplemented with
10% fetal bovine serum (FBS, HyClone), 10 ng/mL GM-CSF (eBioscience),
10 ng/mL IL-4 (eBioscience), and 50 mM 2-ME (Sigma-Aldrich). Cell cultures
in 24-well plates were maintained at 37C in a 5% CO2-humidified atmo-
sphere. Cells were collected on day 3 and analyzed by flow cytometry.
ARG1 Enzymatic Activity Assay
Details of the ARG1 activity measurement can be found in the Supplemental
Experimental Procedures.3230 Cell Reports 17, 3219–3232, December 20, 2016DSS-Induced Experimental Colitis
Colitis was induced by oral administration of 2% DSS (w/v) (MP
Biomedicals, molecular weight [MW] = 36,000–50,000 Da) in the drinking
water for 5 days followed by normal drinking water. Mice were checked
each day for morbidity, and their body weights were recorded. After
the mice were sacrificed, colons were dissected, and colon length was
measured.
Colon Organ Culture and Cytokine Measurement
After mice were sacrificed, colons were dissected, and 1 3 1 cm
standardized segments of colon tissue were washed in cold PBS
supplemented with penicillin and streptomycin (Gibco). These seg-
ments were cultured in 24-well flat-bottom culture plates in serum-
free RPMI 1640 medium (HyClone) supplemented with penicillin and
streptomycin. After 24 hr, supernatants were collected to measure produc-
tion of IFN-g, IL-17A, and IL-10 using cytometric bead array kits (BD
Biosciences) according to the manufacturer’s instructions. A standard
curve was generated using the respective lyophilized recombinant murine
cytokines.
Histology and Scoring
Specimens were fixed with 4% neutral buffered formalin and embedded
in paraffin. Sections were cut, deparaffinized, and stained with H&E. Details
of histological grading can be found in the Supplemental Experimental
Procedures.
Proliferation Assay for Treg Cells and MDSCs
Cells were isolated via a FACSAria III instrument (BD Biosciences) on the ba-
sis of cell surface marker staining. The isolated cells were stained with 5 mM
of CFSE (eBioscience) for 5 min, and then the labeling was stopped by the
addition of RPMI 1640 medium (HyClone) supplemented with 10% FBS
(HyClone). After several washes, CFSE-labeled cells were incubated for
48–72 hr.
TGF-b Knockdown in Treg Cells
Wild-type Treg cells (CD4+CD25+) were isolated from lymph nodes of C57BL/6
mice with a FACSAria III instrument (BD Biosciences). Details of TGF-b
knockdown in Treg cells can be found in the Supplemental Experimental
Procedures.
In Vitro Suppression Assays
Details of the CD4+ T cell suppression assay can be found in the Supplemental
Experimental Procedures.
Fluorescence Imaging
Details of fluorescence labeling and the fluorescence imaging method can be
found in the Supplemental Experimental Procedures.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism 7. All data are pre-
sented as the mean ± SD. A Student’s t test was performed to analyze two
sets of data. For analysis of multiple datasets, one-way ANOVA was used
with Bonferroni, Tukey, or Holm-Sidak post-test, and two-way ANOVA was
used with Bonferroni post-test. For all statistical analyses, p < 0.05 was
considered to be statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2016.11.062.
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